ABVX vs. ZNTL, OPK, OCUL, SAVA, ETNB, MGNX, PRAX, ARQT, IMNM, and SPRY Should you be buying ABIVAX Société Anonyme stock or one of its competitors? The main competitors of ABIVAX Société Anonyme include Zentalis Pharmaceuticals (ZNTL), OPKO Health (OPK), Ocular Therapeutix (OCUL), Cassava Sciences (SAVA), 89bio (ETNB), MacroGenics (MGNX), Praxis Precision Medicines (PRAX), Arcutis Biotherapeutics (ARQT), Immunome (IMNM), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical preparations" industry.
Zentalis Pharmaceuticals (NASDAQ:ZNTL ) and ABIVAX Société Anonyme (NASDAQ:ABVX ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings.
Zentalis Pharmaceuticals' return on equity of 0.00% beat ABIVAX Société Anonyme's return on equity.
47.9% of ABIVAX Société Anonyme shares are held by institutional investors. 6.1% of Zentalis Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Zentalis Pharmaceuticals presently has a consensus price target of $31.67, suggesting a potential upside of 162.36%. ABIVAX Société Anonyme has a consensus price target of $32.00, suggesting a potential upside of 134.60%. Given ABIVAX Société Anonyme's higher possible upside, analysts plainly believe Zentalis Pharmaceuticals is more favorable than ABIVAX Société Anonyme.
Zentalis Pharmaceuticals received 47 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users. However, 71.43% of users gave ABIVAX Société Anonyme an outperform vote while only 65.00% of users gave Zentalis Pharmaceuticals an outperform vote.
In the previous week, Zentalis Pharmaceuticals had 2 more articles in the media than ABIVAX Société Anonyme. MarketBeat recorded 5 mentions for Zentalis Pharmaceuticals and 3 mentions for ABIVAX Société Anonyme. ABIVAX Société Anonyme's average media sentiment score of 0.75 beat Zentalis Pharmaceuticals' score of 0.00 indicating that Zentalis Pharmaceuticals is being referred to more favorably in the media.
Summary Zentalis Pharmaceuticals and ABIVAX Société Anonyme tied by winning 5 of the 10 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding ABVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ABIVAX Société Anonyme Competitors List
Related Companies and Tools
